7 results about "Colon polyps" patented technology

This invention belongs to the field of probiotic screening and application technology, specifically relating to a strain of *Lactobacillus paracasei* and its application in the prevention and treatment of colonic polyps and colon cancer. The *Lactobacillus paracasei*, named *Lactobacillus paracasei* V85, was deposited on January 15, 2026, at the China Center for Type Culture Collection (CCTCC), Wuhan University, China, with accession number CCTCC NO: M2026124. The *Lactobacillus paracasei* V85 provided by this invention is sensitive to common antibiotics and has good biosafety; it possesses strong antioxidant function and a strong inhibitory effect on hemolytic streptococci; it can produce a strong agglutination effect with hemolytic streptococci, which is beneficial for inhibiting the colonization of hemolytic streptococci in the intestine, reducing the risk of colonic polyps and colon cancer caused by hemolytic streptococci, and can promote the proliferation of *Akkermansia myxophilus*. It can be used to prevent and treat colonic polyps and colon cancer caused by hemolytic streptococci, and has broad application prospects.

This invention belongs to the field of functional probiotic screening and application technology, specifically involving a novel strain of *Lactobacillus plantarum* (…). Lactiplantibacillus plantarum The *Lactobacillus plantarum* strain was deposited on January 15, 2026, at the China Center for Type Culture Collection (CCTCC), Wuhan University, Wuhan, China, with accession number CCTCC NO: M202026133. This strain exhibits strong antioxidant capacity, significant inhibitory and flocculating effects against hemolytic streptococci, and can significantly reduce the levels of pro-inflammatory cytokines IL-6 and IL-1β induced by hemolytic streptococci while increasing the level of the anti-inflammatory cytokine IL-22. It has no toxic effects on the body, good safety profile, and can be used to prevent colonic polyps and colon cancer caused by hemolytic streptococci, showing broad application prospects.

This invention belongs to the field of functional probiotic screening and application technology, specifically relating to a strain of *Lactobacillus plantarum* with the function of preventing and treating colon polyps and colon cancer, and its application. The *Lactobacillus plantarum* was deposited on January 15, 2026, at the China Center for Type Culture Collection (CCTCC), Wuhan University, China, with accession number CCTCC NO: M202026126. This strain can significantly inhibit the growth of hemolytic streptococci that induce colon polyps and colon cancer risk, and produces a flocculation effect with hemolytic streptococci, thus having important application value for the prevention and treatment of colon polyps and colon cancer.

This invention belongs to the field of probiotic screening and application technology, specifically relating to a strain of *Lactobacillus rhamnosus* and its application in the prevention and treatment of colon polyps and colon cancer. The *Lactobacillus rhamnosus* is named *Lactobacillus rhamnosus* (…). Lacticaseibacillus rhamnosus S28, deposited on January 15, 2026, at the China Center for Type Culture Collection (CCTCC), Wuhan University, Wuhan, China, with accession number CCTCC NO: M2026129, exhibits strong inhibitory activity against *Streptococcus bovis* and demonstrates a strong agglutination effect with it. It can be used to prevent or treat colonic polyps and colon cancer caused by *Streptococcus bovis*. This invention also provides probiotic pellets containing *Lactobacillus rhamnosus* S28, which exhibit strong resistance, effectively protecting the probiotics from gastric digestion, ensuring their smooth arrival in the intestines, and achieving rapid disintegration within the intestines, showing broad market prospects.

The application relates to the technical field of image processing, in particular to a colon polyp image determination device based on a parameterized algorithm. A processor in the device is used to execute the following steps: obtaining a plurality of initial polyp images in a complex plane parameterized image of the inner wall surface of a colon; the complex plane parameterized image is an image of the inner wall surface of the colon after conformal parameterization; intercepting a three-dimensional polyp curved surface piece of each initial polyp image in the three-dimensional curved surface of the inner wall surface of the colon; and determining a target polyp image from the plurality of initial polyp images according to the geometric features of the three-dimensional polyp curved surface piece corresponding to each initial polyp image. The application can determine the colon polyp image, considers the global curvature of the inner wall surface of the colon to be detected, avoids the problems of detection errors caused by uneven CT density in the polyp and missed detection of the polyp image caused by the shielding of the wrinkle, and improves the accuracy of determining the colon polyp image.

This invention belongs to the field of probiotic screening and application technology, specifically relating to a strain of *Bifidobacterium longum* subsp. *longum* and probiotic pellets containing this strain, as well as their applications. The *Bifidobacterium longum* subsp. *longum* has the accession number CCTCC NO: M2026130 and can significantly inhibit the growth of *Streptococcus pyogenes*, and can efficiently flocculate with *Streptococcus pyogenes*. The probiotic pellets provided by this invention have strong acid resistance, enteric solubility, and storage stability, and can be widely used for the prevention or treatment of *Streptococcus pyogenes*-induced colonic polyps and colon cancer, showing broad prospects.

This invention belongs to the field of probiotic screening and application technology, specifically relating to a strain of *Lactobacillus plantarum*, probiotic pellets containing this strain, their preparation method, and applications. The *Lactobacillus plantarum*, isolated from the feces of healthy infants, has preventative and antagonistic effects against *Streptococcus bovis* infection in the intestines. It was deposited on January 15, 2026, at the China Center for Type Culture Collection (CCTCC), Wuhan University, China, with accession number CCTCC NO: M2026125. This strain exhibits strong tolerance to the digestive tract environment, antioxidant properties, and significantly promotes the proliferation of beneficial intestinal bacteria such as *Lactobacillus acidophilus*, *Lactobacillus casei*, and *Lactobacillus rhamnosus*. It has broad prospects for use in the prevention or treatment of *Streptococcus bovis*-induced colonic polyps and colon cancer.